首页> 外文期刊>Retina >SCORE STUDY REPORT 12 Development of Venous Collaterals in the Score Study
【24h】

SCORE STUDY REPORT 12 Development of Venous Collaterals in the Score Study

机译:评分研究报告12评分研究中静脉侧支的发展

获取原文
获取原文并翻译 | 示例
       

摘要

Purpose: To investigate the prevalence of venous collaterals after branch and central retinal vein occlusion, assess the association of venous collaterals with other clinical features (including visual acuity), and determine if treatment with intravitreal corticosteroids influences the development of new venous collaterals. Methods: Review of data from two multicenter randomized clinical trials in the Standard of Care versus COrticosteroid for REtinal Vein Occlusion (SCORE) Study. Results: Statistically significant associations of venous collaterals and visual acuity at baseline or at follow-up were not found. Treatment with intravitreal triamcinolone acetonide did not appear to influence the development of venous collaterals. Conclusion: In contrast to some previous reports, development of venous collaterals did not demonstrate an independent association with visual acuity in eyes with branch retinal vein occlusion or central retinal vein occlusion in the SCORE Study. Intravitreal steroid effects do not appear to influence the development of venous collaterals.
机译:目的:调查分支和视网膜中央静脉闭塞后静脉侧支的患病率,评估静脉侧支与其他临床特征(包括视力)的关联,并确定玻璃体内糖皮质激素治疗是否影响新的静脉侧支的发展。方法:回顾了两项标准的护理相对于皮质类固醇的视网膜静脉阻塞研究的两项多中心随机临床试验的数据。结果:在基线或随访时未发现静脉侧支与视敏度有统计学意义的关联。玻璃体腔注射曲安奈德治疗似乎没有影响静脉侧支的发展。结论:与先前的一些报道相比,SCORE研究中静脉侧支的发育没有显示与分支视网膜静脉闭塞或视网膜中央静脉闭塞的眼睛的视敏度独立相关。玻璃体内类固醇的作用似乎并不影响静脉侧支的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号